Growth factor receptor signalling: location, location, location.
Ligand binding to plasma membrane receptors initiates a series of events culminating in a variety of changes in cellular phenotypes. Although numerous publications have documented the activation/inactivation of signalling molecules following receptor binding, relatively few investigations have focused on the cellular compartment responsible for either initiating or selecting the particular pathway that mediates the response. Specifically, does receptor signalling occur only at the plasma membrane; is signalling dependent upon the location of defined endosome populations; or are components of both plasma membrane and endosomal activity operative depending upon the particular signalling pathway or cell type? This review addresses aspects of these questions by discussing the evidence supporting or contrasting the interplay between the endocytic and signalling systems for a subset of tyrosine kinase, serine/threonine kinase and G-protein-coupled receptors.
Leof
E B
EB
Depts of Medicine and Biochemistry and Molecular Biology, Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, MN 55905, USA. leof.edward@mayo.edu
D000818:Animals; D006133:Growth Substances / Q000502:physiology*; D006801:Humans; D017978:Receptors, Growth Factor / Q000502:physiology*; D015398:Signal Transduction / Q000502:physiology*
D006133:Growth Substances; D017978:Receptors, Growth Factor